Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-DA-23-003

Investigating Transposable Elements and Mobile DNA as Targets of Integration for Establishing HIV Reservoirs in the Brain (R61/R33 - Clinical Trial Optional)

Closed on August 3, 2022.

Posted
February 11, 2022
Close date
August 3, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $722,475 in first-year total cost, median $722,475.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 BSW-A (J1)]1

Most frequent institutions

  1. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
Competing awards under RFA-DA-23-003 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023HERV proteogenomics of narcotic-driven HIV latency1R61DA058294-01MULDER, LUBBERTUS CICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY$722,475ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works
RFA-DA-23-003: Investigating Transposable Elements and Mobile DNA as Targets of Integration for Establishing HIV Reservoirs in the Brain (R61/R33 - Clinical Trial Optional) | ScienceDex | ConductScience